COS.L Regulatory News (COS)

Collagen Solutions Plc

(the "Company" or the "Group")

Director/PDMR Shareholding

The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative is pleased to announce that Mr. Malcolm Gillies, Non-Executive Director of the Company, has today purchased 438,714 ordinary shares in the Company at 9p per share.

Following this transaction, Mr. Gillies total beneficial holding has increased to 1,653,000 ordinary shares representing 0.96 per cent of the issued ordinary share capital of the Company.

Enquiries: